Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance - Report - MDSpire

Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance

  • By

  • Ramon Marcelino do Nascimento

  • Andrey dos Santos

  • Dioze Guadagnini

  • Lucas Santos de Santana

  • Augusto Cezar Junior Santomauro

  • Caroline Gouveia Buff Passone

  • Milena Gurgel Teles Bezerra

  • Larissa Garcia Gomes

  • Maria Lucia Corrêa-Giannella

  • Marcia Nery

  • Mario José Abdalla Saad

  • Delmar Muniz Junior Lourenço

  • Maria Adelaide Albergaria Pereira

  • May 7, 2026

  • 0 min

Share

Clinical Report: Pathogenic Variants in the Insulin Receptor Gene Linked to Hyperinsulinemic Hypoglycemia

Overview

This study characterizes the metabolic and phenotypic spectrum of individuals with pathogenic variants in the insulin receptor gene (INSR) associated with hyperinsulinemic hypoglycemia (HH) and insulin resistance (IR). The findings highlight a distinct metabolic profile and intrafamilial variability, suggesting a semidominant inheritance pattern.

Background

Hyperinsulinemic hypoglycemia is a rare condition with diverse causes, including genetic factors. Pathogenic germline variants in the INSR gene are among the rarest causes of HH, leading to significant clinical implications. Understanding these variants is crucial for accurate diagnosis, genetic counseling, and management of affected individuals.

Data Highlights

FamilyPGV-INSR TypeHH PrevalenceIR PresencePCOS in Women
F1–F54 heterozygous, 1 homozygous78% (18/23)100%60%

Key Findings

  • 78% of individuals with PGV-INSR experienced hyperinsulinemic hypoglycemia, primarily postprandial.
  • All carriers exhibited insulin resistance, with 60% of women having polycystic ovary syndrome (PCOS).
  • Marked intrafamilial variability was observed, with both dominant and recessive inheritance patterns present.
  • A distinct metabolic signature included normal BMI, elevated insulin levels, and postprandial hypoglycemia with ketonemia.
  • The study supports the concept of semidominant inheritance for INSR-related disorders.

Clinical Implications

Recognition of the metabolic phenotype associated with PGV-INSR can aid in the timely diagnosis and management of hyperinsulinemic hypoglycemia. Clinicians should consider genetic testing for INSR variants in families with a history of hypoglycemia and insulin resistance.

Conclusion

Pathogenic variants in the insulin receptor gene present a unique metabolic profile that necessitates awareness among healthcare providers for improved clinical outcomes. Further research is warranted to explore the implications of semidominant inheritance in these disorders.

References

  1. Collin-Chavagnac et al., The Journal of Clinical Endocrinology & Metabolism, 2025 -- Pathogenic Variants in the Insulin Receptor Gene Linked to Hyperinsulinemic Hypoglycemia
  2. Frontiers in Endocrinology, 2026 -- Case Report: A novel likely pathogenic GCK variant in a young Chinese girl with severe insulin resistance
  3. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Nationwide Cohort Analysis of Clinical and Genetic Features of Congenital Hyperinsulinism in Norway
  4. International Guidelines for the Diagnosis and Management of Hyperinsulinism - PubMed, 2023
  5. INSR-Related Severe Insulin Resistance Syndrome - GeneReviews® - NCBI Bookshelf
  6. The Journal of Clinical Endocrinology & Metabolism — Mosaic GCK Mutations at Low Levels in Pediatric Patients with Congenital Hyperinsulinism Unresponsive to Diazoxide
  7. INSR Disorders Overview
  8. Genetic Testing in Hyperinsulinism
  9. Insulin receptor variants: Extending the traditional Mendelian spectrum - ScienceDirect

Original Source(s)

Related Content